Peptides for Muscle Growth
Research overview of peptides studied for muscle growth, hypertrophy, and body composition. Growth hormone secretagogues, SARMs research, and evidence quality.
Research Overview
Peptide research for muscle growth primarily centers on growth hormone secretagogues (GHSs) and their potential to stimulate endogenous GH release. Unlike exogenous growth hormone, these peptides work through the body's natural regulatory systems.
Growth hormone releasing peptides (GHRPs) like GHRP-2, GHRP-6, and hexarelin have been studied for decades, though most research remains preclinical. Growth hormone releasing hormone (GHRH) analogs like CJC-1295 and sermorelin offer alternative mechanisms for GH stimulation.
The evidence base for muscle-specific applications is generally weaker than for metabolic conditions, with most human data coming from studies focused on growth hormone deficiency rather than healthy adults seeking hypertrophy. Researchers should note that many popular peptides lack rigorous human trial data for muscle-building applications.
Research Landscape
Muscle growth peptide research falls into several mechanistic categories:
Growth Hormone Secretagogues
| Peptide | Mechanism | Evidence Level |
|---|---|---|
| Ipamorelin | Selective GHSR agonist | Low |
| GHRP-6 | GHSR agonist | Low |
| GHRP-2 | GHSR agonist | Low |
| Hexarelin | GHSR agonist | Low |
| MK-677 | Non-peptide GHSR agonist | Moderate |
GHRH Analogs
| Peptide | Mechanism | Evidence Level |
|---|---|---|
| CJC-1295 | GHRH analog (with DAC) | Low |
| Sermorelin | GHRH analog | Moderate |
| Tesamorelin | GHRH analog | High (for lipodystrophy) |
Important Context
Most GH secretagogues were developed for treating growth hormone deficiency, not enhancing muscle growth in healthy individuals. The extrapolation to hypertrophy applications often exceeds the evidence base.
IGF-1 Pathway
IGF-1 and its variants (IGF-1 LR3, mechano-growth factor) represent another research area, though evidence for muscle-specific applications remains limited to preclinical and small observational studies.
Peptides Studied for Muscle Growth
CJC-1295
ModerateA synthetic analog of growth hormone-releasing hormone (GHRH) with extended half-life. Limited clinical development; not approved for any indication.
Follistatin
ModerateAn endogenous glycoprotein that inhibits myostatin and activin signaling, potentially allowing muscle growth beyond genetic limits. Gene therapy trials for muscular dystrophy show promise, but injectable peptide forms remain unapproved and understudied in humans.
IGF-1 LR3
LowA modified form of IGF-1 with an extended half-life due to reduced binding protein affinity. Used primarily in research for muscle growth and metabolic effects. Not approved for human use; significant safety concerns exist.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. The peptides listed may or may not have regulatory approval. Always consult a qualified healthcare provider before making any health decisions.